News & Magazines

Quick Reads about Wellness
View All
NPR
3 min read
Relationships & Parenting

Charlie Gard, Baby Whose Parents Battled Hospital Over Treatment, Dies

Charlie Gard, the British baby with a terminal illness who became subject to a high-profile legal dispute, has died in hospice care, according to multiple media reports. The Guardian, citing Gard's parents, reports that the infant died on Friday, one day after being transferred to an unidentified hospice facility. Charlie had an rare genetic disorder known as MMDS, which affected his brain and his muscles. He could not move his limbs or breathe on his own. His case moved from family tragedy to international legal drama because of a disagreement between his parents and his doctors over his care
NPR
5 min read

There's Great News — And Grim News — In The Fight Against HIV/AIDS

As the International AIDS Conference took place in Paris this week, UNAIDS issued a report with an encouraging statistic. For the first time, more than half of the 36.7 million people with HIV have access to treatment. That means most people with HIV are taking the antiretroviral medicines needed to suppress the virus. The report cited 53 percent, compared to roughly 27 percent in 2012. The news is a reminder of how the HIV/AIDS epidemic is ever-changing. There are promising trends. And there are setbacks as well. We talked with Annemarie Hou, chief of staff at UNAIDS, the United Nations progr
The Atlantic
2 min read
Society

Charlie Gard, Terminally Ill British Baby, Dies, His Parents Say

Charlie Gard, the 11-month-old terminally ill British baby, has died, his parents announced Friday, just days after ending their legal challenge to take him to the U.S. for experimental treatment. “Our beautiful little boy has gone, we are so proud of you Charlie,” his parents said in a statement. Connie Yates and Chris Gard, Charlie’s parents, ended Monday their legal fight to take him to the U.S. after a specialist who examined the baby said it was too late to treat him with experimental nucleoside therapy. Charlie had been on life support since October 2016—and following his parents’ decisi